{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:50:06Z","timestamp":1782741006101,"version":"3.54.5"},"publisher-location":"New York, NY","reference-count":120,"publisher":"Springer New York","isbn-type":[{"value":"9781493926268","type":"print"},{"value":"9781493926275","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-1-4939-2627-5_2","type":"book-chapter","created":{"date-parts":[[2015,8,2]],"date-time":"2015-08-02T13:31:22Z","timestamp":1438522282000},"page":"49-67","source":"Crossref","is-referenced-by-count":33,"title":["Application of Systems Theory in Longitudinal Studies on the Origin and Progression of Alzheimer\u2019s Disease"],"prefix":"10.1007","author":[{"given":"Simone","family":"Lista","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaven S.","family":"Khachaturian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Rujescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Garaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Hampel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"2_CR1","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","volume":"368","author":"K Blennow","year":"2006","unstructured":"Blennow K, De Leon MJ, Zetterberg H (2006) Alzheimer\u2019s disease. Lancet 368:387\u2013403","journal-title":"Lancet"},{"key":"2_CR2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.neuron.2010.10.013","volume":"68","author":"L Bertram","year":"2010","unstructured":"Bertram L, Lill CM, Tanzi RE (2010) The genetics of Alzheimer disease: back to the future. Neuron 68:270\u2013281","journal-title":"Neuron"},{"key":"2_CR3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/B978-0-12-385883-2.00008-4","volume":"107","author":"L Bertram","year":"2012","unstructured":"Bertram L, Tanzi RE (2012) The genetics of Alzheimer\u2019s disease. Prog Mol Biol Transl Sci 107:79\u2013100","journal-title":"Prog Mol Biol Transl Sci"},{"key":"2_CR4","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1001\/archneur.64.8.1148","volume":"64","author":"VM Van Deerlin","year":"2007","unstructured":"Van Deerlin VM, Wood EM, Moore P et al (2007) Clinical, genetic, and pathologic characteristics of patients with frontotemporal dementia and progranulin mutations. Arch Neurol 64:1148\u20131153","journal-title":"Arch Neurol"},{"key":"2_CR5","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/ana.20969","volume":"60","author":"ED Huey","year":"2006","unstructured":"Huey ED, Grafman J, Wassermann EM et al (2006) Characteristics of frontotemporal dementia patients with a Progranulin mutation. Ann Neurol 60:374\u2013380","journal-title":"Ann Neurol"},{"key":"2_CR6","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1001\/2013.jamaneurol.393","volume":"70","author":"DC Perry","year":"2013","unstructured":"Perry DC, Lehmann M, Yokoyama JS et al (2013) Progranulin mutations as risk factors for Alzheimer disease. JAMA Neurol 70:774\u2013778","journal-title":"JAMA Neurol"},{"key":"2_CR7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/alzrt137","volume":"4","author":"SC Jin","year":"2012","unstructured":"Jin SC, Pastor P, Cooper B et al (2012) Pooled-DNA sequencing identifies novel causative variants in PSEN1, GRN and MAPT in a clinical early-onset and familial Alzheimer\u2019s disease Ibero-American cohort. Alzheimers Res Ther 4:34","journal-title":"Alzheimers Res Ther"},{"key":"2_CR8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1001\/archneurol.2010.113","volume":"67","author":"BJ Kelley","year":"2010","unstructured":"Kelley BJ, Haidar W, Boeve BF et al (2010) Alzheimer disease-like phenotype associated with the c.154delA mutation in progranulin. Arch Neurol 67:171\u2013177","journal-title":"Arch Neurol"},{"key":"2_CR9","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/brain\/awn352","volume":"132","author":"N Finch","year":"2009","unstructured":"Finch N, Baker M, Crook R et al (2009) Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members. Brain 132:583\u2013591","journal-title":"Brain"},{"key":"2_CR10","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1001\/archneur.64.10.1436","volume":"64","author":"N Brouwers","year":"2007","unstructured":"Brouwers N, Nuytemans K, van der Zee J et al (2007) Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family. Arch Neurol 64:1436\u20131446","journal-title":"Arch Neurol"},{"key":"2_CR11","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter WJ, Saunders AM, Schmechel D et al (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 90:1977\u20131981","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2_CR12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng1934","volume":"39","author":"L Bertram","year":"2007","unstructured":"Bertram L, McQueen MB, Mullin K et al (2007) Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet 39:17\u201323","journal-title":"Nat Genet"},{"key":"2_CR13","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","volume":"41","author":"D Harold","year":"2009","unstructured":"Harold D, Abraham R, Hollingworth P et al (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease. Nat Genet 41:1088\u20131093","journal-title":"Nat Genet"},{"key":"2_CR14","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","volume":"41","author":"JC Lambert","year":"2009","unstructured":"Lambert JC, Heath S, Even G et al (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease. Nat Genet 41:1094\u20131099","journal-title":"Nat Genet"},{"key":"2_CR15","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1001\/jama.2010.574","volume":"303","author":"S Seshadri","year":"2010","unstructured":"Seshadri S, Fitzpatrick AL, Ikram MA et al (2010) Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 303:1832\u20131840","journal-title":"JAMA"},{"key":"2_CR16","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng.803","volume":"43","author":"P Hollingworth","year":"2011","unstructured":"Hollingworth P, Harold D, Sims R et al (2011) Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer\u2019s disease. Nat Genet 43:429\u2013435","journal-title":"Nat Genet"},{"key":"2_CR17","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ng.801","volume":"43","author":"AC Naj","year":"2011","unstructured":"Naj AC, Jun G, Beecham GW et al (2011) Common variants at MS4A4\/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer\u2019s disease. Nat Genet 43:436\u2013441","journal-title":"Nat Genet"},{"key":"2_CR18","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1586\/erm.10.48","volume":"10","author":"T Zetzsche","year":"2010","unstructured":"Zetzsche T, Rujescu D, Hardy J et al (2010) Advances and perspectives from genetic research: development of biological markers in Alzheimer\u2019s disease. Expert Rev Mol Diagn 10:667\u2013690","journal-title":"Expert Rev Mol Diagn"},{"key":"2_CR19","doi-asserted-by":"crossref","first-page":"e13950","DOI":"10.1371\/journal.pone.0013950","volume":"5","author":"L Jones","year":"2010","unstructured":"Jones L, Holmans PA, Hamshere ML et al (2010) Genetic evidence implicates the immune system and cholesterol metabolism in the etiology of Alzheimer\u2019s disease. PLoS One 5:e13950","journal-title":"PLoS One"},{"key":"2_CR20","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert JC, Ibrahim-Verbaas CA, Harold D et al (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet 45:1452\u20131458","journal-title":"Nat Genet"},{"key":"2_CR21","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, Stefansson H, Steinberg S et al (2013) Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N Engl J Med 368:107\u2013116","journal-title":"N Engl J Med"},{"key":"2_CR22","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J et al (2013) TREM2 variants in Alzheimer\u2019s disease. N Engl J Med 368:117\u2013127","journal-title":"N Engl J Med"},{"key":"2_CR23","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1056\/NEJMe1213157","volume":"368","author":"H Neumann","year":"2013","unstructured":"Neumann H, Daly MJ (2013) Variant TREM2 as risk factor for Alzheimer\u2019s disease. N Engl J Med 368:182\u2013184","journal-title":"N Engl J Med"},{"key":"2_CR24","first-page":"431","volume":"37","author":"S Chinn","year":"1989","unstructured":"Chinn S (1989) Longitudinal studies: design and analysis. Rev Epidemiol Sante Publique 37:431\u2013441","journal-title":"Rev Epidemiol Sante Publique"},{"key":"2_CR25","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3928\/00485713-20081201-03","volume":"38","author":"RD Gibbons","year":"2008","unstructured":"Gibbons RD (2008) Design and analysis of longitudinal studies. Psychiatr Ann 38:758\u2013761","journal-title":"Psychiatr Ann"},{"key":"2_CR26","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1038\/mt.2010.127","volume":"18","author":"C Liu","year":"2010","unstructured":"Liu C, Cripe TP, Kim MO (2010) Statistical issues in longitudinal data analysis for treatment efficacy studies in the biomedical sciences. Mol Ther 18:1724\u20131730","journal-title":"Mol Ther"},{"key":"2_CR27","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/nrneurol.2012.202","volume":"8","author":"H Hampel","year":"2012","unstructured":"Hampel H, Lista S (2012) Alzheimer disease: from inherited to sporadic AD-crossing the biomarker bridge. Nat Rev Neurol 8:598\u2013600","journal-title":"Nat Rev Neurol"},{"key":"2_CR28","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jalz.2012.05.2116","volume":"8","author":"H Hampel","year":"2012","unstructured":"Hampel H, Lista S, Khachaturian ZS (2012) Development of biomarkers to chart all Alzheimer\u2019s disease stages: the royal road to cutting the therapeutic Gordian Knot. Alzheimers Dement 8:312\u2013336","journal-title":"Alzheimers Dement"},{"key":"2_CR29","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s12603-013-0003-1","volume":"17","author":"H Hampel","year":"2013","unstructured":"Hampel H, Lista S (2013) Use of biomarkers and imaging to assess pathophysiology, mechanisms of action and target engagement. J Nutr Health Aging 17:54\u201363","journal-title":"J Nutr Health Aging"},{"key":"2_CR30","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1750-1326-8-20","volume":"8","author":"C Ros\u00e9n","year":"2013","unstructured":"Ros\u00e9n C, Hansson O, Blennow K et al (2013) Fluid biomarkers in Alzheimer\u2019s disease - current concepts. Mol Neurodegener 8:20","journal-title":"Mol Neurodegener"},{"key":"2_CR31","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jalz.2012.11.003","volume":"9","author":"MC Carrillo","year":"2013","unstructured":"Carrillo MC, Blennow K, Soares H et al (2013) Global standardization measurement of cerebral spinal fluid for Alzheimer\u2019s disease: an update from the Alzheimer\u2019s Association Global Biomarkers Consortium. Alzheimers Dement 9:137\u2013140","journal-title":"Alzheimers Dement"},{"key":"2_CR32","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","volume":"12","author":"VL Villemagne","year":"2013","unstructured":"Villemagne VL, Burnham S, Bourgeat P et al (2013) Amyloid \u03b2 deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: a prospective cohort study. Lancet Neurol 12:357\u2013367","journal-title":"Lancet Neurol"},{"key":"2_CR33","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","volume":"367","author":"RJ Bateman","year":"2012","unstructured":"Bateman RJ, Xiong C, Benzinger TL et al (2012) Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease. N Engl J Med 367:795\u2013804","journal-title":"N Engl J Med"},{"key":"2_CR34","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.tins.2008.10.003","volume":"32","author":"F Noorbakhsh","year":"2009","unstructured":"Noorbakhsh F, Overall CM, Power C (2009) Deciphering complex mechanisms in neurodegenerative diseases: the advent of systems biology. Trends Neurosci 32:88\u2013100","journal-title":"Trends Neurosci"},{"key":"2_CR35","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nature01510","volume":"422","author":"M Tyers","year":"2003","unstructured":"Tyers M, Mann M (2003) From genomics to proteomics. Nature 422:193\u2013197","journal-title":"Nature"},{"key":"2_CR36","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1007\/s11427-013-4557-2","volume":"56","author":"Z Dong","year":"2013","unstructured":"Dong Z, Chen Y (2013) Transcriptomics: advances and approaches. Sci China Life Sci 56:960\u2013967","journal-title":"Sci China Life Sci"},{"key":"2_CR37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrg2484","volume":"10","author":"Z Wang","year":"2009","unstructured":"Wang Z, Gerstein M, Snyder M (2009) RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 10:57\u201363","journal-title":"Nat Rev Genet"},{"key":"2_CR38","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1152\/physiolgenomics.00242.2007","volume":"33","author":"WS Liang","year":"2008","unstructured":"Liang WS, Dunckley T, Beach TG et al (2008) Altered neuronal gene expression in brain regions differentially affected by Alzheimer\u2019s disease: a reference data set. Physiol Genomics 33:240\u2013256","journal-title":"Physiol Genomics"},{"key":"2_CR39","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jnr.22290","volume":"88","author":"MG Tan","year":"2010","unstructured":"Tan MG, Chua WT, Esiri MM et al (2010) Genome wide profiling of altered gene expression in the neocortex of Alzheimer\u2019s disease. J Neurosci Res 88:1157\u20131169","journal-title":"J Neurosci Res"},{"key":"2_CR40","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.neurobiolaging.2006.08.004","volume":"28","author":"OC Maes","year":"2007","unstructured":"Maes OC, Xu S, Yu B et al (2007) Transcriptional profiling of Alzheimer blood mononuclear cells by microarray. Neurobiol Aging 28:1795\u20131809","journal-title":"Neurobiol Aging"},{"key":"2_CR41","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/jnr.10351","volume":"70","author":"V Colangelo","year":"2002","unstructured":"Colangelo V, Schurr J, Ball MJ et al (2002) Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: transcription and neurotrophic factor down-regulation and upregulation of apoptotic and pro-inflammatory signaling. J Neurosci Res 70:462\u2013473","journal-title":"J Neurosci Res"},{"key":"2_CR42","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1073\/pnas.0308512100","volume":"101","author":"EM Blalock","year":"2004","unstructured":"Blalock EM, Geddes JW, Chen KC et al (2004) Incipient Alzheimer\u2019s disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci U S A 101:2173\u20132178","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2_CR43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0969-9961(02)00009-8","volume":"12","author":"PJ Yao","year":"2003","unstructured":"Yao PJ, Zhu M, Pyun EI et al (2003) Defects in expression of genes related to synaptic vesicle trafficking in frontal cortex of Alzheimer\u2019s disease. Neurobiol Dis 12:97\u2013109","journal-title":"Neurobiol Dis"},{"key":"2_CR44","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jalz.2009.07.001","volume":"6","author":"P Fehlbaum-Beurdeley","year":"2010","unstructured":"Fehlbaum-Beurdeley P, Jarrige-Le Prado AC, Pallares D et al (2010) Toward an Alzheimer\u2019s disease diagnosis via high-resolution blood gene expression. Alzheimers Dement 6:25\u201338","journal-title":"Alzheimers Dement"},{"key":"2_CR45","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.nbd.2011.05.023","volume":"43","author":"KD Chen","year":"2011","unstructured":"Chen KD, Chang PT, Ping YH et al (2011) Gene expression profiling of peripheral blood leukocytes identifies and validates ABCB1 as a novel biomarker for Alzheimer\u2019s disease. Neurobiol Dis 43:698\u2013705","journal-title":"Neurobiol Dis"},{"key":"2_CR46","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3233\/JAD-2010-101518","volume":"23","author":"BB Booij","year":"2011","unstructured":"Booij BB, Lindahl T, Wetterberg P et al (2011) A gene expression pattern in blood for the early detection of Alzheimer\u2019s disease. J Alzheimers Dis 23:109\u2013119","journal-title":"J Alzheimers Dis"},{"key":"2_CR47","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3233\/JAD-2012-120637","volume":"32","author":"P Fehlbaum-Beurdeley","year":"2012","unstructured":"Fehlbaum-Beurdeley P, Sol O, D\u00e9sir\u00e9 L et al (2012) Validation of AclarusDx\u2122, a blood-based transcriptomic signature for the diagnosis of Alzheimer\u2019s disease. J Alzheimers Dis 32:169\u2013181","journal-title":"J Alzheimers Dis"},{"key":"2_CR48","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3233\/JAD-121963","volume":"35","author":"G Han","year":"2013","unstructured":"Han G, Wang J, Zeng F et al (2013) Characteristic transformation of blood transcriptome in Alzheimer\u2019s disease. J Alzheimers Dis 35:373\u2013386","journal-title":"J Alzheimers Dis"},{"key":"2_CR49","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/elps.11501601185","volume":"16","author":"VC Wasinger","year":"1995","unstructured":"Wasinger VC, Cordwell SJ, Cerpa-Poljak A et al (1995) Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium. Electrophoresis 16:1090\u20131094","journal-title":"Electrophoresis"},{"key":"2_CR50","doi-asserted-by":"crossref","first-page":"471","DOI":"10.33549\/physiolres.931758","volume":"59","author":"V Tambor","year":"2010","unstructured":"Tambor V, Fuc\u00edkov\u00e1 A, Lenco J et al (2010) Application of proteomics in biomarker discovery: a primer for the clinician. Physiol Res 59:471\u2013497","journal-title":"Physiol Res"},{"key":"2_CR51","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2217\/bmm.09.84","volume":"4","author":"M Thambisetty","year":"2010","unstructured":"Thambisetty M, Lovestone S (2010) Blood-based biomarkers of Alzheimer\u2019s disease: challenging but feasible. Biomark Med 4:65\u201379","journal-title":"Biomark Med"},{"key":"2_CR52","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1002\/elps.200500892","volume":"27","author":"M Becker","year":"2006","unstructured":"Becker M, Schindler J, Nothwang HG (2006) Neuroproteomics \u2013 the tasks lying ahead. Electrophoresis 27:2819\u20132829","journal-title":"Electrophoresis"},{"key":"2_CR53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1586\/14789450.2.1.1","volume":"2","author":"M Hamacher","year":"2005","unstructured":"Hamacher M, Meyer HE (2005) HUPO Brain Proteome Project: aims and needs in proteomics. Exp Rev Proteomics 2:1\u20133","journal-title":"Exp Rev Proteomics"},{"key":"2_CR54","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/nbt1235","volume":"24","author":"N Rifai","year":"2006","unstructured":"Rifai N, Gillette MA, Carr SA et al (2006) Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol 24:971\u2013983","journal-title":"Nat Biotechnol"},{"key":"2_CR55","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000334537","volume":"10","author":"E Portelius","year":"2012","unstructured":"Portelius E, Gustavsson MK, Zetterberg H et al (2012) Evaluation of the performance of novel A\u03b2 isoforms as theragnostic markers in Alzheimer\u2019s disease: from the cell to the patient. Neurodegener Dis 10:138\u2013140","journal-title":"Neurodegener Dis"},{"key":"2_CR56","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.neurobiolaging.2009.06.002","volume":"32","author":"E Portelius","year":"2011","unstructured":"Portelius E, Price E, Brinkmalm G et al (2011) A novel pathway for amyloid precursor protein processing. Neurobiol Aging 32:1090\u20131098","journal-title":"Neurobiol Aging"},{"key":"2_CR57","doi-asserted-by":"crossref","first-page":"e16032","DOI":"10.1371\/journal.pone.0016032","volume":"6","author":"RJ Perrin","year":"2011","unstructured":"Perrin RJ, Craig-Schapiro R, Malone JP et al (2011) Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer\u2019s disease. PLoS One 6:e16032","journal-title":"PLoS One"},{"key":"2_CR58","doi-asserted-by":"crossref","first-page":"e18850","DOI":"10.1371\/journal.pone.0018850","volume":"6","author":"R Craig-Schapiro","year":"2011","unstructured":"Craig-Schapiro R, Kuhn M, Xiong C et al (2011) Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer\u2019s disease diagnosis and prognosis. PLoS One 6:e18850","journal-title":"PLoS One"},{"key":"2_CR59","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.biopsych.2010.08.025","volume":"68","author":"R Craig-Schapiro","year":"2010","unstructured":"Craig-Schapiro R, Perrin RJ, Roe CM et al (2010) YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer\u2019s disease. Biol Psychiatry 68:903\u2013912","journal-title":"Biol Psychiatry"},{"key":"2_CR60","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/alzrt30","volume":"2","author":"E Portelius","year":"2010","unstructured":"Portelius E, Dean RA, Gustavsson MK et al (2010) A novel Abeta isoform pattern in CSF reflects gamma-secretase inhibition in Alzheimer disease. Alzheimers Res Ther 2:7","journal-title":"Alzheimers Res Ther"},{"key":"2_CR61","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/prca.200900166","volume":"4","author":"V Albertini","year":"2010","unstructured":"Albertini V, Bruno A, Paterlini A et al (2010) Optimization protocol for amyloid-\u03b2 peptides detection in human cerebrospinal fluid using SELDI TOF MS. Proteomics Clin Appl 4:352\u2013357","journal-title":"Proteomics Clin Appl"},{"key":"2_CR62","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1159\/000203774","volume":"6","author":"E Portelius","year":"2009","unstructured":"Portelius E, Brinkmalm G, Tran AJ et al (2009) Identification of novel APP\/Abeta isoforms in human cerebrospinal fluid. Neurodegener Dis 6:87\u201394","journal-title":"Neurodegener Dis"},{"key":"2_CR63","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.neurobiolaging.2007.01.011","volume":"29","author":"AH Simonsen","year":"2008","unstructured":"Simonsen AH, McGuire J, Podust VN et al (2008) Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer\u2019s disease. Neurobiol Aging 29:961\u2013968","journal-title":"Neurobiol Aging"},{"key":"2_CR64","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1001\/archneur.64.3.366","volume":"64","author":"AH Simonsen","year":"2007","unstructured":"Simonsen AH, McGuire J, Hansson O et al (2007) Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment. Arch Neurol 64:366\u2013370","journal-title":"Arch Neurol"},{"key":"2_CR65","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1159\/000110576","volume":"24","author":"AH Simonsen","year":"2007","unstructured":"Simonsen AH, McGuire J, Podust VN et al (2007) A novel panel of cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer\u2019s disease versus normal aging and frontotemporal dementia. Dement Geriatr Cogn Disord 24:434\u2013440","journal-title":"Dement Geriatr Cogn Disord"},{"key":"2_CR66","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/ana.21038","volume":"61","author":"EJ Finehout","year":"2007","unstructured":"Finehout EJ, Franck Z, Choe LH et al (2007) Cerebrospinal fluid proteomic biomarkers for Alzheimer\u2019s disease. Ann Neurol 61:120\u2013129","journal-title":"Ann Neurol"},{"key":"2_CR67","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1021\/pr0703627","volume":"6","author":"E Portelius","year":"2007","unstructured":"Portelius E, Tran AJ, Andreasson U et al (2007) Characterization of amyloid beta peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry. J Proteome Res 6:4433\u20134439","journal-title":"J Proteome Res"},{"key":"2_CR68","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neulet.2006.09.044","volume":"409","author":"E Portelius","year":"2006","unstructured":"Portelius E, Zetterberg H, Andreasson U et al (2006) An Alzheimer\u2019s disease-specific beta amyloid fragment signature in cerebrospinal fluid. Neurosci Lett 409:215\u2013219","journal-title":"Neurosci Lett"},{"key":"2_CR69","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1021\/pr050475v","volume":"5","author":"E Portelius","year":"2006","unstructured":"Portelius E, Westman-Brinkmalm A, Zetterberg H et al (2006) Determination of beta-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation\u2013mass spectrometry. J Proteome Res 5:1010\u20131016","journal-title":"J Proteome Res"},{"key":"2_CR70","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1002\/pmic.200300470","volume":"3","author":"O Carrette","year":"2003","unstructured":"Carrette O, Demalte I, Scherl A et al (2003) A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer\u2019s disease. Proteomics 3:1486\u20131494","journal-title":"Proteomics"},{"key":"2_CR71","doi-asserted-by":"publisher","DOI":"10.1097\/WAD.0b013e31827b60d2","author":"LH Guo","year":"2013","unstructured":"Guo LH, Alexopoulos P, Wagenpfeil S (2013) Plasma proteomics for the identification of Alzheimer disease. Alzheimer Dis Assoc Disord. doi:10.1097\/WAD.0b013e31827b60d2","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"2_CR72","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1001\/archneurol.2012.1282","volume":"69","author":"JD Doecke","year":"2012","unstructured":"Doecke JD, Laws SM, Faux NG et al (2012) Blood-based protein biomarkers for diagnosis of Alzheimer disease. Arch Neurol 69:1318\u20131325","journal-title":"Arch Neurol"},{"key":"2_CR73","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1212\/WNL.0b013e318266fa70","volume":"79","author":"WT Hu","year":"2012","unstructured":"Hu WT, Holtzman DM, Fagan AM et al (2012) Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease. Neurology 79:897\u2013905","journal-title":"Neurology"},{"key":"2_CR74","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1001\/archneurol.2012.1070","volume":"69","author":"HD Soares","year":"2012","unstructured":"Soares HD, Potter WZ, Pickering E et al (2012) Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease. Arch Neurol 69:1310\u20131317","journal-title":"Arch Neurol"},{"key":"2_CR75","doi-asserted-by":"crossref","first-page":"e34341","DOI":"10.1371\/journal.pone.0034341","volume":"7","author":"D Johnstone","year":"2012","unstructured":"Johnstone D, Milward EA, Berretta R et al (2012) Multivariate protein signatures of pre-clinical Alzheimer\u2019s disease in the Alzheimer\u2019s disease neuroimaging initiative (ADNI) plasma proteome dataset. PLoS One 7:e34341","journal-title":"PLoS One"},{"key":"2_CR76","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000330750","volume":"32","author":"SE O\u2019Bryant","year":"2011","unstructured":"O\u2019Bryant SE, Xiao G, Barber R et al (2011) A blood-based algorithm for the detection of Alzheimer\u2019s disease. Dement Geriatr Cogn Disord 32:55\u201362","journal-title":"Dement Geriatr Cogn Disord"},{"key":"2_CR77","doi-asserted-by":"crossref","first-page":"e28092","DOI":"10.1371\/journal.pone.0028092","volume":"6","author":"SE O\u2019Bryant","year":"2011","unstructured":"O\u2019Bryant SE, Xiao G, Barber R et al (2011) A blood-based screening tool for Alzheimer\u2019s disease that spans serum and plasma: findings from TARC and ADNI. PLoS One 6:e28092","journal-title":"PLoS One"},{"key":"2_CR78","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1001\/archneurol.2010.215","volume":"67","author":"SE O\u2019Bryant","year":"2010","unstructured":"O\u2019Bryant SE, Xiao G, Barber R et al (2010) A serum protein-based algorithm for the detection of Alzheimer disease. Arch Neurol 67:1077\u20131081","journal-title":"Arch Neurol"},{"key":"2_CR79","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm1653","volume":"13","author":"S Ray","year":"2007","unstructured":"Ray S, Britschgi M, Herbert C et al (2007) Classification and prediction of clinical Alzheimer\u2019s diagnosis based on plasma signaling proteins. Nat Med 13:1359\u20131362","journal-title":"Nat Med"},{"key":"2_CR80","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1093\/brain\/awl279","volume":"129","author":"A Hye","year":"2006","unstructured":"Hye A, Lynham S, Thambisetty M et al (2006) Proteome-based plasma biomarkers for Alzheimer\u2019s disease. Brain 129:3042\u20133050","journal-title":"Brain"},{"key":"2_CR81","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2013.01.013","author":"K Henriksen","year":"2013","unstructured":"Henriksen K, O\u2019Bryant SE, Hampel H et al (2013) The future of blood-based biomarkers for Alzheimer\u2019s disease. Alzheimers Dement. doi:10.1016\/j.jalz.2013.01.013","journal-title":"Alzheimers Dement"},{"key":"2_CR82","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/alzrt185","volume":"5","author":"VB Gupta","year":"2013","unstructured":"Gupta VB, Sundaram R, Martins RN (2013) Multiplex biomarkers in blood. Alzheimers Res Ther 5:31","journal-title":"Alzheimers Res Ther"},{"key":"2_CR83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pneurobio.2012.06.007","volume":"101\u2013102","author":"S Lista","year":"2013","unstructured":"Lista S, Faltraco F, Prvulovic D et al (2013) Blood and plasma-based proteomic biomarker research in Alzheimer\u2019s disease. Prog Neurobiol 101\u2013102:1\u201317","journal-title":"Prog Neurobiol"},{"key":"2_CR84","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","volume":"6","author":"K Blennow","year":"2010","unstructured":"Blennow K, Hampel H, Weiner M et al (2010) Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 6:131\u2013144","journal-title":"Nat Rev Neurol"},{"key":"2_CR85","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1586\/14789450.5.2.225","volume":"5","author":"E Portelius","year":"2008","unstructured":"Portelius E, Zetterberg H, Gobom J et al (2008) Targeted proteomics in Alzheimer\u2019s disease: focus on amyloid-beta. Expert Rev Proteomics 5:225\u2013237","journal-title":"Expert Rev Proteomics"},{"key":"2_CR86","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1155\/2005\/848676","volume":"21","author":"P Davidsson","year":"2005","unstructured":"Davidsson P, Sjogren M (2005) The use of proteomics in biomarker discovery in neurodegenerative diseases. Dis Markers 21:81\u201392","journal-title":"Dis Markers"},{"key":"2_CR87","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1602\/neurorx.1.2.226","volume":"1","author":"MC Irizarry","year":"2004","unstructured":"Irizarry MC (2004) Biomarkers of Alzheimer disease in plasma. NeuroRx 1:226\u2013234","journal-title":"NeuroRx"},{"key":"2_CR88","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2217\/bmm.12.42","volume":"6","author":"AM Fagan","year":"2012","unstructured":"Fagan AM, Perrin RJ (2012) Upcoming candidate cerebrospinal fluid biomarkers of Alzheimer\u2019s disease. Biomark Med 6:455\u2013476","journal-title":"Biomark Med"},{"key":"2_CR89","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1146\/annurev.pharmtox.48.113006.094715","volume":"48","author":"R Kaddurah-Daouk","year":"2008","unstructured":"Kaddurah-Daouk R, Kristal BS, Weinshilboum RM (2008) Metabolomics: a global biochemical approach to drug response and disease. Annu Rev Pharmacol Toxicol 48:653\u2013683","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2_CR90","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/978-0-387-30411-3_33","volume-title":"Handbook of neurochemistry and molecular neurobiology. Brain energetics. Integration of molecular and cellular processes","author":"BS Kristal","year":"2007","unstructured":"Kristal BS, Kaddurah-Daouk R et al (2007) Metabolomics: concept and potential neuroscience application. In: Lajtha A, Gibson G, Dienel G (eds) Handbook of neurochemistry and molecular neurobiology. Brain energetics. Integration of molecular and cellular processes, 3rd edn. Springer, New York, pp 889\u2013912","edition":"3"},{"key":"2_CR91","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2217\/pme.13.8","volume":"10","author":"J Sun","year":"2013","unstructured":"Sun J, Beger RD, Schnackenberg LK (2013) Metabolomics as a tool for personalizing medicine: 2012 update. Personal Med 10:149\u2013161","journal-title":"Personal Med"},{"key":"2_CR92","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1021\/ac051437y","volume":"78","author":"CA Smith","year":"2006","unstructured":"Smith CA, Want EJ, O\u2019Maille G et al (2006) XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem 78:779\u2013787","journal-title":"Anal Chem"},{"key":"2_CR93","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nmeth0211-117","volume":"8","author":"M Baker","year":"2011","unstructured":"Baker M (2011) Metabolomics: from small molecules to big ideas. Nat Methods 8:117\u2013121","journal-title":"Nat Methods"},{"key":"2_CR94","doi-asserted-by":"crossref","first-page":"e63644","DOI":"10.1371\/journal.pone.0063644","volume":"8","author":"E Trushina","year":"2013","unstructured":"Trushina E, Dutta T, Persson XM et al (2013) Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer\u2019s disease using metabolomics. PLoS One 8:e63644","journal-title":"PLoS One"},{"key":"2_CR95","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1046\/j.1471-4159.2002.00997.x","volume":"82","author":"X Han","year":"2002","unstructured":"Han X, MHoltzman D, McKeel DW Jr (2002) Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer\u2019s disease: potential role in disease pathogenesis. J Neurochem 82:809\u2013818","journal-title":"J Neurochem"},{"key":"2_CR96","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/npp.2008.174","volume":"34","author":"R Kaddurah-Daouk","year":"2009","unstructured":"Kaddurah-Daouk R, Krishnan KR (2009) Metabolomics: a global biochemical approach to the study of central nervous system diseases. Neuropsychopharmacology 34:173\u2013186","journal-title":"Neuropsychopharmacology"},{"key":"2_CR97","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/nprot.2011.335","volume":"6","author":"WB Dunn","year":"2011","unstructured":"Dunn WB, Broadhurst D, Begley P et al (2011) Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc 6:1060\u20131083","journal-title":"Nat Protoc"},{"key":"2_CR98","first-page":"4213","volume":"7","author":"K Cottingham","year":"2008","unstructured":"Cottingham K (2008) HUSERMET researchers look to the metabolome for answers. J Proteome Res 7:4213","journal-title":"J Proteome Res"},{"key":"2_CR99","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.bbalip.2010.01.010","volume":"1801","author":"X Han","year":"2010","unstructured":"Han X (2010) Multi-dimensional mass spectrometry-based shotgun lipidomics and the altered lipids at the mild cognitive impairment stage of Alzheimer\u2019s disease. Biochim Biophys Acta 1801:774\u2013783","journal-title":"Biochim Biophys Acta"},{"key":"2_CR100","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.1038\/tp.2013.18","volume":"3","author":"R Kaddurah-Daouk","year":"2013","unstructured":"Kaddurah-Daouk R, Zhu H, Sharma S et al (2013) Alterations in metabolic pathways and networks in Alzheimer\u2019s disease. Transl Psychiatry 3:e244","journal-title":"Transl Psychiatry"},{"key":"2_CR101","doi-asserted-by":"crossref","first-page":"e31501","DOI":"10.1371\/journal.pone.0031501","volume":"7","author":"C Czech","year":"2012","unstructured":"Czech C, Berndt P, Busch K et al (2012) Metabolite profiling of Alzheimer\u2019s disease cerebrospinal fluid. PLoS One 7:e31501","journal-title":"PLoS One"},{"key":"2_CR102","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jalz.2010.06.001","volume":"7","author":"R Kaddurah-Daouk","year":"2011","unstructured":"Kaddurah-Daouk R, Rozen S, Matson W et al (2011) Metabolomic changes in autopsy-confirmed Alzheimer\u2019s disease. Alzheimers Dement 7:309\u2013317","journal-title":"Alzheimers Dement"},{"key":"2_CR103","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1194\/jlr.M022376","volume":"53","author":"Y Sato","year":"2012","unstructured":"Sato Y, Suzuki I, Nakamura T et al (2012) Identification of a new plasma biomarker of Alzheimer\u2019s disease using metabolomics technology. J Lipid Res 53:567\u2013576","journal-title":"J Lipid Res"},{"key":"2_CR104","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1038\/tp.2011.55","volume":"1","author":"M Ore\u0161i\u010d","year":"2011","unstructured":"Ore\u0161i\u010d M, Hy\u00f6tyl\u00e4inen T, Herukka SK et al (2011) Metabolome in progression to Alzheimer\u2019s disease. Transl Psychiatry 1:e57","journal-title":"Transl Psychiatry"},{"key":"2_CR105","doi-asserted-by":"crossref","first-page":"e21643","DOI":"10.1371\/journal.pone.0021643","volume":"6","author":"X Han","year":"2011","unstructured":"Han X, Rozen S, Boyle SH et al (2011) Metabolomics in early Alzheimer\u2019s disease: identification of altered plasma sphingolipidome using shotgun lipidomics. PLoS One 6:e21643","journal-title":"PLoS One"},{"key":"2_CR106","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.cell.2010.11.033","volume":"143","author":"MR Wenk","year":"2010","unstructured":"Wenk MR (2010) Lipidomics: new tools and applications. Cell 143:888\u2013895","journal-title":"Cell"},{"key":"2_CR107","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.plefa.2011.04.021","volume":"85","author":"G Astarita","year":"2011","unstructured":"Astarita G, Piomelli D (2011) Towards a whole-body systems [multi-organ] lipidomics in Alzheimer\u2019s disease. Prostaglandins Leukot Essent Fatty Acids 85:197\u2013203","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"2_CR108","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1371\/journal.pcbi.0030034","volume":"3","author":"PS Niemel\u00e4","year":"2007","unstructured":"Niemel\u00e4 PS, Ollila S, Hyv\u00f6nen MT et al (2007) Assessing the nature of lipid raft membranes. PLoS Comput Biol 3:e34","journal-title":"PLoS Comput Biol"},{"key":"2_CR109","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1194\/jlr.M006494","volume":"51","author":"L Yetukuri","year":"2010","unstructured":"Yetukuri L, S\u00f6derlund S, Koivuniemi A et al (2010) Composition and lipid spatial distribution of HDL particles in subjects with low and high HDL-cholesterol. J Lipid Res 51:2341\u20132351","journal-title":"J Lipid Res"},{"key":"2_CR110","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1126\/science.1069492","volume":"295","author":"H Kitano","year":"2002","unstructured":"Kitano H (2002) Systems biology: a brief overview. Science 295:1662\u20131664","journal-title":"Science"},{"key":"2_CR111","doi-asserted-by":"crossref","first-page":"e1000117","DOI":"10.1371\/journal.pcbi.1000117","volume":"4","author":"S Horvath","year":"2008","unstructured":"Horvath S, Dong J (2008) Geometric interpretation of gene coexpression network analysis. PLoS Comput Biol 4:e1000117","journal-title":"PLoS Comput Biol"},{"key":"2_CR112","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S (2008) WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics 9:559","journal-title":"BMC Bioinformatics"},{"key":"2_CR113","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1752-0509-1-54","volume":"1","author":"P Langfelder","year":"2007","unstructured":"Langfelder P, Horvath S (2007) Eigengene networks for studying the relationships between co-expression modules. BMC Syst Biol 1:54","journal-title":"BMC Syst Biol"},{"key":"2_CR114","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1523\/JNEUROSCI.4098-07.2008","volume":"28","author":"JA Miller","year":"2008","unstructured":"Miller JA, Oldham MC, Geschwind DH (2008) A systems level analysis of transcriptional changes in Alzheimer\u2019s disease and normal aging. J Neurosci 28:1410\u20131420","journal-title":"J Neurosci"},{"key":"2_CR115","doi-asserted-by":"crossref","first-page":"12698","DOI":"10.1073\/pnas.0914257107","volume":"107","author":"JA Miller","year":"2010","unstructured":"Miller JA, Horvath S, Geschwind DH (2010) Divergence of human and mouse brain transcriptome highlights Alzheimer disease pathways. Proc Natl Acad Sci U S A 107:12698\u201312703","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2_CR116","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/bib\/bbm031","volume":"8","author":"MG Kann","year":"2007","unstructured":"Kann MG (2007) Protein interactions and disease: computational approaches to uncover the etiology of diseases. Brief Bioinform 8:333\u2013346","journal-title":"Brief Bioinform"},{"key":"2_CR117","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrg1272","volume":"5","author":"AL Barabasi","year":"2004","unstructured":"Barabasi AL, Oltvai ZN (2004) Network biology: understanding the cell\u2019s functional organization. Nat Rev Genet 5:101\u2013115","journal-title":"Nat Rev Genet"},{"key":"2_CR118","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1089\/omi.2011.0054","volume":"16","author":"P Hallock","year":"2012","unstructured":"Hallock P, Thomas MA (2012) Integrating the Alzheimer\u2019s disease proteome and transcriptome: a comprehensive network model of a complex disease. OMICS 16:37\u201349","journal-title":"OMICS"},{"key":"2_CR119","doi-asserted-by":"crossref","first-page":"D767","DOI":"10.1093\/nar\/gkn892","volume":"37","author":"TSK Prasad","year":"2009","unstructured":"Prasad TSK, Goel R, Kandasamy K et al (2009) Human Protein Reference Database-2009 update. Nucleic Acids Res 37:D767\u2013D772","journal-title":"Nucleic Acids Res"},{"key":"2_CR120","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/gm204","volume":"2","author":"M Ore\u0161i\u010d","year":"2010","unstructured":"Ore\u0161i\u010d M, L\u00f6tj\u00f6nen J, Soininen H (2010) Systems medicine and the integration of bioinformatic tools for the diagnosis of Alzheimer\u2019s disease. Genome Med 2:83","journal-title":"Genome Med"}],"container-title":["Methods in Molecular Biology","Systems Biology of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-2627-5_2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T09:38:04Z","timestamp":1718012284000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-4939-2627-5_2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9781493926268","9781493926275"],"references-count":120,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-2627-5_2","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}